DrugPatentWatch Database Preview
Osmotica Pharm Company Profile
What is the competitive landscape for OSMOTICA PHARM, and what generic alternatives to OSMOTICA PHARM drugs are available?
OSMOTICA PHARM has seven approved drugs.
There are three US patents protecting OSMOTICA PHARM drugs.
There are twenty-nine patent family members on OSMOTICA PHARM drugs in fourteen countries and two supplementary protection certificates in two countries.
Summary for Osmotica Pharm
| International Patents: | 29 |
| US Patents: | 3 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
| Patent Litigation for Osmotica Pharm: | See patent lawsuits for Osmotica Pharm |
Drugs and US Patents for Osmotica Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm Us | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 077127-002 | Nov 21, 2005 | AB2 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Osmotica Pharm Us | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203114-001 | Jan 26, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Osmotica Pharm | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-002 | May 20, 2008 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Osmotica Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Osmotica Pharm | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RE39069 | ➤ Sign Up |
| Osmotica Pharm | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-004 | May 20, 2008 | 6,403,120 | ➤ Sign Up |
| Osmotica Pharm | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-004 | May 20, 2008 | 6,419,958 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Osmotica Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2009517332 | ➤ Sign Up |
| Australia | 7706598 | ➤ Sign Up |
| Mexico | 2007006472 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Osmotica Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0296560 | SPC/GB97/023 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214 |
| 0296560 | 2/1998 | Austria | ➤ Sign Up | PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
